YOLFTbeta
Shanxi Zhendong Pharmaceutical

Shanxi Zhendong Pharmaceutical

300158 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

4.66CNY-0.14 (-2.92%)

Price History

Full chart

Market Stats

Previous Close4.80
Open4.78
Day Range4.65 – 4.80
52-Week Range4.47 – 7.81
Volume9.58M
Market Cap5.17B
P/E (TTM)0.00
Forward P/E33.44
EPS-0.40
Dividend Yield0.00%
Beta0.19
50-Day Avg5.24
200-Day Avg5.59

About

Shanxi Zhendong Pharmaceutical Co.,Ltd, together with its subsidiaries, researches, develops, produces, and sells pharmaceutical drugs in China. The company offers drugs for oncology, dermatology, digestive, urological, and cardiovascular diseases, as well as seeds. It is also involved in the integrating seeds, seedling cultivation, planting, processing, storage; and provision of Chinese medicinal materials and processed medicinal slices. In addition, the company engages in the production of anti-tumor raw materials, small-volume injections, lyophilized powder injections, tablets, hard capsules. granules, and powders. Shanxi Zhendong Pharmaceutical Co.,Ltd was founded in 1995 and is headquartered in Changzhi, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Xufeng Wang
  • Employees3.69K
  • HeadquartersZhendong Science and Technology Park, Changzhi, China, 047100, China
  • Websitehttps://www.zdjt.com

Leadership

  • Mr. Xufeng WangVP & Director · b. 1982
  • Ms. Rongli YouVice President of R&D · b. 1979
  • Mr. Rui WangPresident · b. 1976

Financials

Income Statement

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Total Revenue315.26M461.05M528.69M930.33M1.28B1.39B1.66B1.92B2.26B3.28B3.73B3.42B4.40B4.85B5.09B3.73B3.63B2.97B
Growth (%)-+46.25%+14.67%+75.97%+37.73%+8.25%+19.57%+15.74%+17.85%+45.13%+13.66%-8.36%+28.63%+10.21%+5.07%-26.80%-2.75%-18.06%
Cost of Revenue41.51M92.57M117.03M387.70M599.27M627.40M845.37M1.08B1.24B1.83B1.58B1.18B1.56B1.82B2.06B1.89B1.83B1.81B
Gross Profit273.75M368.48M411.67M542.62M682.11M759.65M813.12M836.29M1.02B1.46B2.15B2.24B2.84B3.02B3.04B1.83B1.80B1.16B
Gross Margin86.83%79.92%77.87%58.33%53.23%54.77%49.03%43.57%45.30%44.36%57.64%65.44%64.57%62.36%59.60%49.20%49.54%39.00%
Operating Expense217.38M294.94M329.34M437.70M563.44M675.36M731.19M812.80M981.83M1.25B1.79B2.32B2.65B2.70B-85.53M1.84B1.83B1.87B
Operating Income56.37M73.55M82.33M104.93M118.66M84.29M81.93M23.49M42.82M206.91M361.34M-83.91M191.10M326.22M3.12B-5.92M-29.98M-714.71M
Operating Margin17.88%15.95%15.57%11.28%9.26%6.08%4.94%1.22%1.89%6.30%9.68%-2.45%4.34%6.73%61.28%-0.16%-0.83%-24.06%
EBITDA71.24M98.16M109.52M130.28M153.45M163.19M154.38M149.76M190.54M379.26M492.93M57.07M334.58M510.75M3.26B134.51M85.19M-1.20B
EBITDA Margin22.60%21.29%20.72%14.00%11.98%11.77%9.31%7.80%8.42%11.55%13.21%1.67%7.61%10.54%64.03%3.61%2.35%-40.48%
Net Income39.23M59.39M68.02M92.09M119.77M91.48M74.02M41.96M64.65M203.06M301.54M-147.44M142.76M262.03M2.62B-51.29M-43.98M-1.33B
Net Income Margin12.44%12.88%12.87%9.90%9.35%6.60%4.46%2.19%2.86%6.19%8.08%-4.31%3.25%5.41%51.38%-1.38%-1.21%-44.72%
R&D-----47.13M41.53M53.69M55.01M81.25M117.93M123.18M145.31M136.19M218.73M178.11M191.02M351.48M
R&D as % of Total Revenue-----3.40%2.50%2.80%2.43%2.47%3.16%3.60%3.30%2.81%4.29%4.78%5.27%11.83%
Interest Expense7.27M12.42M9.34M11.12M8.63M16.91M25.18M26.38M39.39M33.53M24.97M30.43M26.97M21.60M20.33M16.23M2.03M4.33M
Interest Expense % of Total Revenue2.31%2.69%1.77%1.20%0.67%1.22%1.52%1.37%1.74%1.02%0.67%0.89%0.61%0.45%0.40%0.44%0.06%0.15%

Balance Sheet

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Total Assets466.70M496.69M643.18M2.17B2.26B2.58B2.80B2.86B4.07B6.87B7.61B7.21B6.92B7.60B10.09B6.55B6.18B4.98B
Total Liabilities290.28M229.98M283.87M389.13M397.40M684.26M838.64M888.23M2.04B1.60B2.06B1.85B1.47B1.97B2.04B1.33B1.04B1.32B
Total Equity176.42M266.72M358.99M1.76B1.83B1.88B1.95B1.96B1.99B5.25B5.54B5.36B5.44B5.64B8.08B5.25B5.18B3.70B
Cash32.65M29.25M82.11M1.42B668.59M563.24M345.57M238.79M309.55M586.86M606.80M728.14M505.73M926.34M1.22B720.27M800.88M584.59M
Total Debt119.45M92.15M159.82M215.00M128.00M220.00M334.65M323.00M649.69M319.07M446.55M407.91M54.00M414.61M312.72M21.87M1.63M39.20M
Net Debt86.80M62.90M77.72M-1.21B-540.59M-343.24M-10.92M84.21M340.14M-267.80M-160.25M-320.23M-451.73M-511.73M-909.27M-698.39M-798.03M-545.39M

Cash Flow

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Operating Cash Flow128.65M33.18M42.28M32.40M-88.73M189.40M-75.04M73.23M151.84M-44.72M45.09M154.48M186.35M221.94M284.45M86.31M-189.95M-149.82M
Investing Cash Flow-144.21M-34.27M-53.48M-79.97M-470.89M-330.60M-235.31M-153.60M-676.10M-92.29M-107.43M-44.51M-29.10M44.16M348.85M2.39B472.84M39.51M
Financing Cash Flow43.48M-7.31M58.86M1.39B-193.31M13.56M113.46M-61.11M496.26M465.21M147.62M-26.09M-356.51M205.61M-386.46M-2.98B-144.57M-94.49M
Capital Expenditure42.07M29.35M28.01M80.09M347.05M348.75M235.36M144.15M46.92M146.81M47.93M23.92M19.37M183.96M151.66M145.81M116.21M298.48M
Free Cash Flow86.57M3.84M14.27M-47.70M-435.78M-159.35M-310.40M-70.92M104.93M-191.53M-2.85M130.56M166.99M37.98M132.79M-59.50M-365.39M-448.30M
Dividends Paid6.52M10.92M8.86M10.80M51.40M59.65M33.36M54.41M88.42M200.42M49.27M53.87M18.70M51.37M174.67M2.77B1.22M584.65K
FCF to OCF67.30%11.57%33.75%-147.22%491.11%-84.13%413.64%-96.85%69.10%428.29%-6.32%84.52%89.61%17.11%46.68%-68.94%192.36%299.22%
Dividend Paid to FCF7.53%284.50%62.08%-22.64%-11.80%-37.43%-10.75%-76.72%84.27%-104.64%-1729.68%41.26%11.20%135.25%131.54%-4662.40%-0.34%-0.13%

Earnings

Report DateMar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Apr 24, 2015Aug 26, 2015Oct 25, 2015Feb 28, 2016Apr 27, 2016Jun 30, 2016Oct 28, 2016Feb 24, 2017Apr 27, 2017Aug 28, 2017Oct 26, 2017Feb 26, 2018Apr 26, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Apr 27, 2020Aug 21, 2020Oct 30, 2020Dec 31, 2020Apr 27, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023May 17, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024May 16, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate--------------------------------------------------------------
EPS Actual0.040.050.060.060.050.020.040.050.040.020.040.030.030.030.020.000.030.030.030.030.030.030.100.100.060.100.080.060.050.04-0.03-0.200.050.050.030.000.060.050.090.050.100.120.102.230.010.020.00-0.07-0.000.01-0.01-0.040.020.010.01-1.360.000.010.01-0.32-0.00-0.09
Surprise--------------------------------------------------------------
Timing----------------Pre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hours-Pre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-market-----------------------Pre-market---Pre-market-----

Key Statistics & Ratios

Market Cap5.17B
Enterprise Value4.74B
Trailing P/E0.00
Forward P/E33.44
PEG Ratio0.00
Price / Sales2.13
Price / Book1.61
EPS-0.40
Book Value3.28
Revenue (TTM)2.42B
Gross Profit (TTM)1.21B
EBITDA-317.17M
Profit Margin-16.58%
Operating Margin-24.22%
Return on Equity-11.85%
Return on Assets-6.13%
Shares Outstanding992.30M
Shares Float657.81M
Beta0.19
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20221×
2.70May 9, 2022
20212×
0.10Sep 13, 20210.07May 26, 2021
20201×
0.05Jul 21, 2020
20181×
0.02Jun 14, 2018
20171×
0.03Jul 14, 2017
20161×
0.29Jun 6, 2016
20151×
0.05Jul 24, 2015
20141×
0.05Jun 18, 2014
20131×
0.01Jun 24, 2013
20121×
0.07Jul 23, 2012
20111×
0.07May 24, 2011

Stock Splits

  • Jun 14, 20182:1
  • Jul 23, 201220:10